Acute Anxiety Treatment Guidelines

Pharmacological Interventions

The American College of Cardiology is not relevant here, however, first-line options for acute anxiety treatment include benzodiazepines for immediate relief, while SSRIs or SNRIs are recommended for ongoing management, with cognitive behavioral therapy strongly recommended as either standalone or adjunctive treatment, according to Praxis Medical Insights 1
SSRIs, such as escitalopram, paroxetine, and sertraline, have demonstrated efficacy in treating social anxiety disorder, as per Neuropsychopharmacology 2
SNRIs, such as venlafaxine, are effective alternatives when SSRIs are not tolerated or ineffective, as stated in Neuropsychopharmacology and Praxis Medical Insights 3, 1
Pregabalin is considered a first-line option in some guidelines, particularly for generalized anxiety disorder, according to Neuropsychopharmacology 3

Cognitive behavioral therapy (CBT) is strongly recommended as a first-line treatment for anxiety disorders, with evidence supporting its efficacy as either standalone or adjunctive therapy, as per Praxis Medical Insights 1
Individual CBT sessions are preferred over group therapy due to superior clinical and economic effectiveness, according to Neuropsychopharmacology 2
For patients who cannot or do not want face-to-face therapy, self-help with support based on CBT principles is a viable alternative, as stated in Neuropsychopharmacology 2
CBT should be structured with approximately 14 sessions over 4 months, with each session lasting 60-90 minutes, as per Neuropsychopharmacology 2

Initiate an SSRI or SNRI for ongoing management, with options including escitalopram, paroxetine, or sertraline as first-line options, according to Neuropsychopharmacology 2, 3
Concurrently refer for CBT with a skilled therapist, as per Neuropsychopharmacology 2
If medication is ineffective after 8 weeks despite good adherence, consider switching to another SSRI/SNRI or adding a psychological intervention if not already implemented, as stated in Praxis Medical Insights 1
For patients not responding to SSRIs, consider switching to an SNRI like venlafaxine, according to Neuropsychopharmacology 3

Regular monitoring of treatment response using standardized instruments is essential for evaluating effectiveness, as per Praxis Medical Insights 1
Underutilizing psychological interventions like CBT, which have strong evidence for effectiveness in anxiety disorders, is a common pitfall to avoid, according to Neuropsychopharmacology and Praxis Medical Insights 2, 1